The following items were the subject
                        of a Form 12b-25 and are included
                        herein: Item 1. Financial Statements
                        and Item 2. Management's Discussion
                        and Analysis of Financial Condition
                        and Results of Operations. 
 
              SECURITIES AND EXCHANGE COMMISSION 
                   WASHINGTON, D.C.  20549 
 
                        ---------------- 
 
                          FORM 10-Q/A 
 
     [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) 
              OF THE SECURITIES EXCHANGE ACT OF 1934 
              FOR THE PERIOD ENDED SEPTEMBER 30, 1997 
                             OR 
   [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) 
            OF THE SECURITIES EXCHANGE ACT OF 1934 
             FOR THE TRANSITION PERIOD FROM     TO  
 
                        ---------------- 
                 Commission file number 0-18160 
 
                         4HEALTH, INC. 
    (Exact name of registrant as specified in its charter) 
                        ---------------- 
 
         Utah                           87-0468225 
  (State of incorporation)      (I.R.S. Employer Id. No.) 
 
                      5485 Conestoga Court 
                    Boulder, Colorado  80301 
              (Address of principal executive offices) 
          Registrant's telephone number:  (303) 546-6306 
                        ---------------- 
 
Indicate by check mark whether the registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to 
file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.  Yes:  X    No: 
 
The number of shares of the registrant's Common Stock, par value
$.01 per share, outstanding as of September 30, 1997
was 11,905,920. 
 
 
 
 
 
 
4Health, Inc. 
Index to Form 10-Q/AA 
<TABLE> 
<CAPTION> 
<S>                                                   <C> 
                                                      Page 
PART I.  FINANCIAL INFORMATION 
Item 1.  Financial Statements: 
    Condensed Balance Sheets as of September 30, 
         1997 and December 31, 1996....................4 
 
    Condensed Statement of Operations for Three 
         and Nine Months Ended September 30, 1997  
         and 1996......................................5 
 
    Condensed Statements of Cash Flows for Nine 
         Months Ended September 30, 1997 and 1996......6 
 
    Notes to Condensed Financial Statements............7 
 
Item 2.       Management's Discussion and Analysis of 
    Financial Condition and Results of Operations......9 
 
PART II.      OTHER INFORMATION 
Item 6.  Exhibits and Reports on Form 8-K.............13 
SIGNATURES.............................................14 
</TABLE> 
    This Quarterly Report on Form 10-Q/AA includes "forward-
looking statements" within the meaning of Section 27A of the 
Securities Act of 1933, as amended (the "Securities Act") and 
Section 21E of the Securities Exchange Act of 1934, as amended 
(the "Exchange Act").  All statements other than statements of 
historical facts included in this Quarterly Report, including, 
without limitation, those regarding the Company's financial 
position, business, marketing and product introduction and 
development plans and objectives of management for future  
operations, are forward-looking statements.  Although the Company
believes that the expectations reflected in such forward-looking
statements are reasonable, it can give no assurance that such
expectations will prove to have been correct.  Important factors
that could cause actual results to differ materially from the
Company's expectations ("Cautionary Statements") are disclosed
under "Risks Related to the Business of 4Health" and elsewhere in
the Company's Annual Report on Form 10-K dated March 27, 1997 and
in "Management's Discussion and Analysis of Financial Condition
and Results of Operations" and elsewhere in the Annual Report.
All subsequent written and oral forward-looking statements
attributable to the Company or persons acting on behalf of the
Company, are expressly qualified in their entirety by the
Cautionary Statements. 
 
 
 
 
PART I.  FINANCIAL INFORMATION 
Item 1.       Financial Statements 
                        4Health, Inc. 
              Condensed Balance Sheets (Unaudited) 
<TABLE> 
<CAPTION> 
<S>                               <C>               <C> 
                        September 30, 1997  December 31, 1996 
ASSETS 
CURRENT ASSETS 
Cash and cash equivalents    $    290,258      $  1,086,168 
Accounts receivable, net             1,351,021         1,105,207 
Inventories                     1,576,787         2,534,881 
Deferred tax asset                325,190           313,872 
Prepaid expenses                  455,010           171,138 
Notes receivable                   31,830           265,819 
                             ____________      ____________ 
  Total current assets          4,030,096         5,477,085 
PROPERTY AND EQUIPMENT, NET     2,407,122         2,559,629 
PREPAID EXPENSES                  700,000                 0 
OTHER ASSETS, NET                 574,027         1,136,531 
NOTES RECEIVABLE                   87,624           116,308 
                             ____________      ____________ 
  Total assets                    $  7,798,869      $  9,289,553 
                             ============      ============ 
LIABILITIES AND STOCKHOLDERS' EQUITY 
CURRENT LIABILITIES 
Accounts payable             $  1,000,833      $    484,079 
Accrued liabilities                    572,282           878,025 
Taxes payable                      45,300           113,833 
Notes payable                     366,520            20,555 
Capital leases                             694             3,733 
                             ____________      ____________ 
  Total current liabilities     1,985,629         1,500,225 
DEFERRED TAXES                          92,692           152,112 
NOTES PAYABLE                   1,305,269         1,275,716 
STOCKHOLDERS' EQUITY 
Common stock                      119,059           114,603 
Additional paid in capital 
  - common stock                7,883,752         8,226,844 
Additional paid in capital 
  - common warrants                    190,316                 0 
Treasury stock                         (50,000)          (50,000) 
Accumulated deficit                 (3,727,848)       (1,929,947) 
                             ____________      ____________ 
  Total stockholders' equity     4,415,279        6,361,500 
Total liabilities and        ____________      ____________ 
  stockholders' equity       $  7,798,869      $  9,289,553 
                             ============      ============ 
</TABLE> 
 
 
 
         See notes to condensed financial statements. 
                        4Health, Inc. 
              Condensed Statements of Operations 
                         (Unaudited) 
<TABLE> 
<CAPTION> 
                  Three Months Ended      Nine Months Ended 
                        Sept. 30,             Sept. 30, 
                   1997       1996         1997       1996 
<S>                <C>         <C>         <C>         <C> 
Net Sales          $3,076,185  $3,311,507  $10,296,532 $14,791,932 
Cost of goods  
  sold         1,301,328   1,284,440    4,849,056   5,780,097 
               _________   _________   __________  __________ 
Gross margin    1,774,857   2,027,067    5,447,476   9,011,835 
Operating Expenses 
  Sales           490,118     680,936    1,627,971   2,108,099 
  Marketing       868,345   1,217,597    3,171,062   5,313,103 
  Research and  
    development    69,435     136,622      367,841     290,323 
  General and  
    administrative682,218     799,624    2,189,387   2,047,099 
               _________   _________   __________  __________ 
Total operating 
  expenses      2,110,116   2,834,779    7,356,261   9,758,624 
               _________   _________   __________  __________ 
Net income from 
  operations     (335,259)   (807,712)  (1,908,785)   (746,789) 
 
Other income 
  (expense)        11,459      52,480       15,734      28,228 
               _________   _________   __________  __________ 
Net income (loss) 
  before income 
  taxes          (323,800)   (755,232)  (1,893,051)   (718,561) 
 
Income tax benefit 
  (provision)     (52,970)     17,137       88,408      91,776 
               _________   _________   __________  __________ 
NET INCOME(LOSS)$(376,770)  $(738,095) $(1,804,643)  $(626,785) 
               =========   =========   ==========  ========== 
Net income (loss) per 
    common share   $(0.03)     $(0.07)      $(0.16)     $(0.07) 
               =========   =========   ==========  ========== 
Weighted average shares  
    outstanding11,427,693  10,906,635   11,396,393   9,423,827 
 
 
 
</TABLE> 
 
 
 
 
         See notes to condensed financial statements. 
                        4Health, Inc. 
         Condensed Statements of Cash Flows (Unaudited) 
<TABLE> 
<CAPTION> 
                                   Nine Months Ended Sept. 30, 
                                       1997             1996 
CASH FLOWS FROM OPERATING ACTIVITIES     <C>             <C> 
Net income (loss)                $  (1,797,901)   $   (626,785) 
Adjustments to reconcile net income (loss) to 
 net cash provided by operating activities: 
  Depreciation and amortization       241,145         160,875 
  Bad debt expense                     14,565               0 
  Loss on disposal of assets           22,845           4,501 
  Issuance of Warrants                190,316               0 
(Increase) decrease in: 
  Accounts receivable                (260,380)        (74,486) 
  Inventory                           958,094      (1,128,040) 
  Prepaid expenses and other         (916,839)       (463,061) 
  Deferred income tax assets          (11,318)        (82,168) 
 (Increase) decrease in: 
  Accounts payable                    516,754         917,565 
  Accrued liabilities                (305,744)        257,888 
  Taxes payable                       (68,533)         12,287 
  Deferred income tax liability       (59,420)         89,270 
Net cash (used in) from operating    _________       _________ 
  activities                       (1,476,416)       (932,154) 
CASH FLOWS FROM INVESTING ACTIVITIES _________       _________ 
  Proceeds from sale of marketable 
    securities                                   0         524,002 
  Acquisition of SGTI                       0       3,639,257 
  Purchase of fixed assets            (86,261)       (462,009) 
  Proceeds from asset dispositions             600               0 
  Proceeds from note receivable       262,673           5,957 
Net cash from (used in) investing    _________       _________ 
  activities                          177,012       3,707,207 
CASH FLOWS FROM FINANCING ACTIVITIES _________       _________ 
  Proceeds from common stock           130,049          59,330 
  Acquisition costs                              0        (454,866) 
  Borrowings on short-term debt       337,665               0 
  Borrowings on long-term debt      1,350,000               0 
  Repayments on long-term borrowings(1,312,147)       (71,198) 
  Repayments on capital leases         (2,073)         (4,199) 
                                    _________       _________ 
Net cash used in financing activities  503,494       (470,933) 
                                    _________       _________ 
NET (DECREASE) INCREASE IN CASH      (795,910)      2,304,120 
CASH AND CASH EQUIVALENTS, at 
  beginning of period               1,086,168         919,935 
                                    _________       _________ 
CASH AND CASH EQUIVALENTS, at 
  end of period                   $   290,258    $  3,224,055 
                                    =========       ========= 
</TABLE> 
         See notes to condensed financial statements. 
                      4Health, Inc. 
         Notes to Condensed Financial Statements 
                   September 30, 1997 
                      (Unaudited) 
 
Note 1:   
 
Basis of Presentation 
 
    The accompanying unaudited condensed financial statements 
have been prepared in accordance with generally accepted 
accounting principles for interim financial information and  
with the instructions to Form 10-Q and Article 10 of Regulation 
S-X.  Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles 
for complete financial statements.  In the opinion of management,
all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included.
Operating results for the nine month period ended September 30,
1997 are not necessarily indicative of the results that may be
expected for the year ended December 31, 1997.  For further 
information, refer to the consolidated financial statements and
footnotes thereto included in the Form 10-K dated March 31, 1997
and the Company's Proxy Statement dated April 25, 1997. 
 
Note 2:   
 
Certain Sales Transactions 
 
    In February 1997, the Company entered into a negotiated 
settlement with General Nutrition Corporation, Inc. ("GNC") to 
settle all pending litigation between the two parties.  The  
terms of the settlement include the Company supplying GNC with 
certain 4Health products free of charge and taking back certain 
other 4Health products.  The execution of this settlement  
agreement was completed during the first and second quarters of 
1997.   
 
    On February 25, 1997, 4Health entered into a barter 
agreement with Active Media Services, Inc.  Under the terms of 
the agreement, the Company sold to Active Media Services,  
Inc. certain inventory with a cost of $780,308 for which the 
Company received $2,300,000 in barter credits.  These barter 
credits can be used in lieu of cash to purchase goods and 
services available through Active Media Services, Inc.  4Health 
intends to use these barter credits for advertising, printing, 
travel, and other normal operating expenditures.  This 
transaction was recorded at the cost of the product sold to 
Active Media Services, Inc. ($758,308) and the unused  
portion of the barter credits is reflected in the balance sheet 
as a prepaid expense.  As of June 30, 1997, none of the barter 
credits had been used.  Product costing $424,149 was shipped to 
Active Media Services, Inc. during the first quarter with the 
balance of $334,159 shipped in the second quarter 1997. 

Note 3: 
 
Line of Credit 
 
    Effective September 4, 1997, the Company entered into a $1.5
million revolving line of credit with Norwest Business Credit,
Inc.  The line of credit bears interest at the Norwest Bank
Minnesota's Base Rate (currently 8.5%) plus 2.5%.  The available
balance is determined by certain accounts receivable and
inventory.  Any balance outstanding is secured by certain 
accounts receivable, inventory, general intangibles, and any 
unencumbered machinery and equipment. 
 
Note 4: 
 
Issuance of New common Stock 
 
    Pursuant to a clause in the 1996 merger agreement between 
4health, Inc. and Surgical Technologies, Inc., 500,000 new shares
of stock were issued to original 4health, Inc. stockholders on
September 26, 1997.  The merger agreement stated that in the
event the surviving company did not realize at least $2,000,000
in Inflation Device Technology earnings within 12 months
subsequent to the closing date (July 15, 1996) of the merger, the
number of shares of New Common Stock issuable to the original
4health shareholders would be increased on a pro rata basis. 
 
Note 5: 
 
Subsequent Event - Merger Agreement 
 
    On October 13, 1997, 4Health executed a letter of intent to
acquire Irwin Naturals, Inc. ("INI") a privately held California
corporation engaged in the nutritional supplement business.  The
merger would result in INI becoming a wholly owned subsidiary of
4Health in consideration of the issuance of 15,750,000 restricted
shares of 4Health common stock.  The transaction is conditioned
upon the execution of a definitive acquisition agreement.  
 








 





Item 2.  Management's Discussion and Analysis of Financial 
Condition and Results of Operations 
 
    See the disclosure regarding forward looking statements 
above. 
 
Results of Operations 
 
Comparison of Third Quarter 1997 to 1996 
 
Net sales for the three months ended September 30, 1997, 
decreased 7.1% to $3.1 million from $3.3 million compared to the
same period a year ago.  Net sales in the Nature's Secret brand
were down 9.2%, or $253 thousand, for the third quarter 1997
compared to the third quarter 1996 due primarily to increased
competition and overall weakness in healthfood store sales.  
 
Gross margin percentage decreased 3.5 % for the quarter ended 
September 30, 1997 down to 57.7% from 61.2% for the same period 
in 1996.  Management attributes this decrease to a shift in  
sales of products with an overall lower profit margin.  Gross 
margin for the third quarter 1997 declined 12% to $1.8 million 
from $2.0 million in the third quarter of 1996.  Management  
attributes this decline to a combination of the drop in net sales
revenue and the drop in gross margin percentage due to change in
sales product mix. 
 
Operating expenses dropped 25% in the third quarter of 1997 to 
$2.1 million compared to $2.8 in the third quarter of 1996.  
Marketing expenses decreased $350 thousand or 29% from $1.2  
million to $870 thousand in the third quarter ended September 30,
1997 as compared to the third quarter of 1996 due mainly to an
overall reduction in advertising, advertising development and 
marketing personnel costs.  Management believes a more focused
and grassroots approach to its marketing strategy will not only
be far less expensive but also more effective.  Sales expenses 
decreased $191 thousand or 28% from $681 thousand to $490
thousand in the third quarter ended September 30, 1997 as 
compared to the same quarter in 1996 due mainly to a reduction 
in personnel, primarily in the outside sales force.  General and
administrative expenses decreased 15% to $682 thousand in the
third quarter 1997 compared to $800 thousand in third quarter
1996.  The decrease was due to the efforts of management to
reduce corporate overhead.  This reduction in general and
administrative expenses covered a broad range of expense
categories and amounted to $213 thousand which was offset by $103
thousand in investment banking fees incurred in the third quarter
of 1997 which were nonexistent in 1996.  4Health's research and
development department decreased spending $67 thousand in the
third quarter 1997 compared to the third  quarter 1996.  This
decrease was due to costs incurred in the third quarter of 1996
involving a clinical study of one of its products.  The company
had no clinical studies in progress in the third quarter of 1997. 
 
Interest income decreased 86% to $12 thousand in the third 
quarter 1997 from $86 thousand in the third quarter 1996.  The 
reason for this decrease was the average balance of cash and 
cash equivalents in the third quarter of 1997 was less than 
the average balance during the same period a year earlier. 
 
The Company reported a net loss of $384 thousand, or $.03 per 
share, for the three months ended September 30, 1997 compared 
to a net loss of $738 thousand, or $.06 per share, for the 
three months ended September 30, 1996. 
 
Comparison of Year-to-Date 1997 to 1996 
 
Net sales for the nine months ended September 30, 1997, 
decreased 30.0% or $4.5 million to $10.3 million from $14.8 
million compared to the same period a year ago.  Net sales in 
the Nature's Secret brand were down 39%, or $5.4 million, year-
to-date 1997 compared to year-to-date 1996 due primarily to a 
drop in 1997 sales to a major customer of $3.1 million and a 
drop in 1997 Nature's Secret sales other than to that major 
customer of $3.0 million.  Offsetting those decreases in 1997, 
were an increase in 1997 net sales in the Mass Market division 
of $900 thousand and a $758 thousand sale to a barter company, 
Active Media Services, Inc.  Excluding net sales to a major 
customer and to Active Media, net sales decreased $1.4 million 
or 14% for the nine months ended September 30, 1997 when 
compared to the same period a year earlier. 
 
Gross margin decreased 40% to $5.4 million year-to-date 1997 
from $9 million for the same period in 1996.  Gross margin 
percentage for the nine months ended September 30, 1997 
declined 8% when compared to the same period in 1996. 
Management attributes 5% of this decline to the $758 thousand 
sale to Active Media Services, Inc., which was recorded at 
cost, and the other 3% to a shift in sales to products with 
an overall lower profit margin and to more aggressive 
discounting due to competitive pressures in the first half of 
the year. 
 
Operating expenses were down 25% for the nine months ended 
September 30, 1997 to $7.4 million compared to $9.8 million for 
the nine months ended September 30, 1996.  The ongoing plan by 
management to bring sales and marketing costs in line with 
existing revenues is the reason for this decrease.  Marketing 
expenses decreased 40%, or $2.1 million, for the nine months 
ended September 30, 1997 to $3.2 million compared to $5.3 
million for the same period in 1996.  The decrease in marketing 
expenses in 1997 came from a reduction in advertising in the 
amount of $1.4 million with the balance of the decrease created 
primarily by personnel and promotion cuts.  Sales expenses 
declined 23% to $1.6 million year-to-date in 1997 from $2.1  
million for the same period in 1996.  Reduction in personnel 
and related selling expenses account for most of this decrease 
in 1997.  General and administrative expenses increased 7%, or 
$140 thousand, to $2.2 million year-to-date 1997 compared to 
$2.0 million year-to-date 1996.  This increase was due 
primarily to an increase in legal fees during the first half of 
1997 and investment banking fees incurred in 1997 and not in 
1996.  4Health's research and development department increased 
spending 27%, or $77 thousand, year-to-date 1997 compared to 
1996.  This increase was due to the costs associated with 
clinical studies that were conducted in the first half  
of 1997. 
 
Interest income decreased 57%, or $63 thousand, to $48 thousand 
year-to-date 1997 from $111 thousand year-to-date 1996.  The 
reason for this decrease was the amount of cash and cash 
equivalents available for investment in interest bearing 
accounts was down compared to the amount available at the 
end of 1996. 
 
The Company reported a net loss of $1.8 million, or $.16 per 
share, for the nine months ended September 30, 1997 compared to 
a net loss of $627 thousand, or $.07 per share, for the nine 
months ended September 30, 1996. 
 
Liquidity and Capital Resources 
 
The Company's cash and cash equivalents position at September 
30, 1997, was $.3 million compared to $1.1 million on December 
31, 1996.  The $.8 million decrease in cash and cash 
equivalents position was a result of these resources being used 
to fund ongoing operations.  The Company has a working capital 
ratio of 2 to 1. 
 
The Company invests it's cash in an interest bearing money market
account. 
 
Accounts receivable totaled $1.35 million at September 30, 1997 
as compared to $1.1 million on December 31, 1996.  This $.25 
million or 23% increase was due to primarily to the longer 
collection cycle for mass market related sales. 
 
Inventories were valued at $1.6 million at September 30, 1997 as
compared to $2.5 million at December 31, 1996, which represents
36% decrease or $.9 million. This decrease was due primarily to
the sale to Active Media Services, Inc. of $.75 million. 
 
The Company's prepaid advertising and promotion costs related to
its UnDo product, as well as, prepaid costs associated with the
introduction of new products and packaging caused short term
prepaid expenses to increase to $.5 million at September 30, 1997
from $.2 million at December 31, 1996.  This represents an
increase of 250%. 
 
Notes receivable decreased $263 thousand to $119 thousand at 
September 30, 1997 from $382 thousand at December 31, 1996. This
was due to the collection of funds owed to Surgical Technologies,
Inc. prior to the merger of 4Health and Surgical. 
 
Capital expenditures for the first nine months of 1997 were $86 
thousand compared to $462 thousand for the same period in 1996. 
 
Other assets, net decreased 50% at September 30, 1997 from $1.1 
million at December 31, 1996 to $574 thousand due primarily to 
an adjustment in the value of certain intangible assets related 
to the issuance of additional shares of stock on September 26, 
1997 to original 4health, Inc. shareholders of record at the time
of the merger with Surgical Technologies, Inc.  (See Note 4 of
the Notes to Condensed Financial Statements of this Form 10-
Q/AA.) 
 
Accounts payable and accrued liabilities increased $.2 million at
September 30, 1997 to $1.6 million compared to the balance on
December 31, 1996 and is related primarily to amounts due  
suppliers for inventory and unpaid advertising and promotion 
costs. 
 
Notes payable increased to $367 thousand at September 30 1997 
from $21 thousand at December 31, 1996 due to the company 
borrowing on its revolving line of credit which was negotiated 
and activated during the current quarter.  Available borrowing 
capacity in addition to amounts outstanding at September 30, 
1997 was $630 thousand. 
 
The deferred tax liability decreased $60 thousand due to 
interim tax estimates by management. 
 
Additional paid-in capital decreased $343 thousand to $7.9 
million at September 30, 1997 from $8.2 million at December 31, 
1996.  This decrease was due primarily to an adjustment related 
to the issuance of additional shares of stock on September 26, 
1997 to original 4health, Inc. shareholders of record at the time
of the merger with Surgical Technologies, Inc.  (See Note 4 of
the Notes to Condensed Financial Statements of this Form 10-
Q/AA.) This adjustment was partially offset by an increase in
additional paid-in capital related to warrants as of September
30, 1997 in the amount of $190 thousand as compared to $0 at
December 31, 1996.  These warrant costs relate to warrant
certificates issued on April 15, 1997 in which warrants are to be
exchanged for investment banking and consulting services. 
 
Additional paid in capital related to warrants as of September 
30, 1997 was $190 thousand as compared to $0 at December 31, 
1996.  These warrant costs relate to warrant certificates issued
on April 15, 1997 in which warrants are to be exchanged for
investment banking and consulting services. 
 
As previously mentioned, the Company has $.3 million in cash 
reserves at September 30, 1997 and working capital of $2 million
with a 2 to 1 working capital ratio.  Former Surgical 
Stockholders were issued 1,135,554 warrants and, if exercise at 
an $11.00 exercise price, could generate $12.5 million in cash 
for 4Health, Inc.  These Warrants expire 18 months from the  
issuance date of July 15, 1996 and likelihood of them being 
exercised is dependent on the performance of the 4Health, Inc. 
Common Stock. As the stock price exceeds $11.00 per share, the 
probability of exercise increases.  Currently, the stock is 
trading in the vicinity of $6.50 per share. 
 
The Company's future capital requirements will depend on many 
factors, including the nature and timing of orders from 
customers, collection of accounts on trade sales, the level of 
sales and marketing efforts, costs associated with entering into
new channels of distribution, and the status of competitive
products. 
 
Management believes that its working capital and borrowing 
capacity will be sufficient to satisfy anticipated sales growth 
and investment in facilities for at least 12 months.  The Company
continues to seek additional financing for future needs.  There
can be no assurance, however, that the Company will not require
additional financing earlier than anticipated.  Further, there
can be no assurance that any additional financing will be
available at acceptable terms, or at all.  The inability to
obtain such financing could have a material adverse effect on the
Company's business, financial condition, and results of
operations. 
 
Part II.      OTHER INFORMATION 
Item 6.  Exhibits and Reports of Form 8-K 
 
Item 27. Financial Data Schedule. This Filing. 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
  







Signatures  
 
    Pursuant to the requirements of the Securities Exchange 
Act of 1934, the registrant has duly caused this report to be 
signed on its behalf by the undersigned thereunto duly 
authorized. 
 
 
                             4Health, Inc. 
 
Dated: November 18, 1997 
By:/s/ R. LINDSEY DUNCAN 
R. Lindsey Duncan 
President and Chief Executive Officer 
 
Dated: November 18, 1997 
By:/s/ SCOTT W. LUSK 
Scott W. Lusk 
Controller (Principal Accounting Officer)